Table 2 Moderate adverse events occurring during immunoadsorption that were classified as being related to vascular access, the immunoadsorption procedure or immunosuppression
Patients (n = 11) | Immunoadsorption therapies (n = 55) | |
|---|---|---|
Vascular access-related | ||
Central venous catheter exit site infection | 1 (9.1%) | 1 (1.8%) |
Jugular vein thrombosis | 1 (9.1%) | 1 (1.8%) |
Side effects during immunoadsorption therapy | ||
Chest pain | 1 (9.1%) | 1 (1.8%) |
Dyspnoe | 1 (9.1%) | 1 (1.8%) |
Transient hypotension | 4 (36.5%) | 5 (9.1%) |
Urticaria | 1 (9.1%) | 1 (1.8%) |
Putatively related to immunosuppression both by steroids and immunoadsorption | ||
Febrile infection | 2 (18.2%) | 2 (3.6%) |